Search Results

There are 22440 results for: content related to: NF-κB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants

  1. New insights into small-molecule inhibitors of Bcr-Abl

    Medicinal Research Reviews

    Volume 31, Issue 1, January 2011, Pages: 1–41, S. Schenone, O. Bruno, M. Radi and M. Botta

    Version of Record online : 27 AUG 2009, DOI: 10.1002/med.20175

  2. You have free access to this content
    Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl–positive cells

    Cytometry Part A

    Volume 62A, Issue 1, November 2004, Pages: 35–45, Vanessa Desplat, Valérie Lagarde, Francis Belloc, Claudine Chollet, Thibaut Leguay, Jean-Max Pasquet, Vincent Praloran and François-Xavier Mahon

    Version of Record online : 5 OCT 2004, DOI: 10.1002/cyto.a.20030

  3. You have free access to this content
    Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein

    Cancer

    Volume 100, Issue 7, 1 April 2004, Pages: 1459–1471, Barbara Scappini, Simona Gatto, Francesco Onida, Clara Ricci, Vladimir Divoky, William G. Wierda, Michael Andreeff, Li Dong, Kimberly Hayes, Srdan Verstovsek, Hagop M. Kantarjian and Miloslav Beran

    Version of Record online : 25 FEB 2004, DOI: 10.1002/cncr.20131

  4. You have full text access to this Open Access content
    Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: Biochemical evidence and therapeutic perspectives

    Molecular Oncology

    Volume 7, Issue 6, December 2013, Pages: 1103–1115, Christian Borgo, Luca Cesaro, Valentina Salizzato, Maria Ruzzene, Maria Lina Massimino, Lorenzo A. Pinna, Arianna Donella-Deana

    Version of Record online : 22 AUG 2013, DOI: 10.1016/j.molonc.2013.08.006

  5. You have free access to this content
    Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells

    British Journal of Pharmacology

    Volume 158, Issue 2, September 2009, Pages: 588–600, Jelena Klawitter, Douglas J Kominsky, Jaimi L Brown, Jost Klawitter, Uwe Christians, Dieter Leibfritz, Junia V Melo, S Gail Eckhardt and Natalie J Serkova

    Version of Record online : 6 AUG 2009, DOI: 10.1111/j.1476-5381.2009.00345.x

  6. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  7. You have free access to this content
    Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines

    Cancer

    Volume 103, Issue 1, 1 January 2005, Pages: 102–110, Vanessa Desplat, Francis Belloc, Valérie Lagarde, Catherine Boyer, Junia V. Melo, Josy Reiffers, Vincent Praloran and François-Xavier Mahon

    Version of Record online : 22 NOV 2004, DOI: 10.1002/cncr.20758

  8. You have free access to this content
    Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

    European Journal of Haematology

    Volume 87, Issue 5, November 2011, Pages: 381–393, Shantashri Vaidya, Kanjaksha Ghosh and Babu Rao Vundinti

    Version of Record online : 2 OCT 2011, DOI: 10.1111/j.1600-0609.2011.01689.x

  9. You have free access to this content
    Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL

    International Journal of Cancer

    Volume 122, Issue 12, 15 June 2008, Pages: 2744–2752, Tim Beissert, Alena Hundertmark, Velina Kaburova, Lorena Travaglini, Afsar A. Mian, Clara Nervi and Martin Ruthardt

    Version of Record online : 25 MAR 2008, DOI: 10.1002/ijc.23467

  10. You have full text access to this Open Access content
    Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: In vitro and in vivo studies

    Cancer Science

    Volume 99, Issue 6, June 2008, Pages: 1251–1257, Daigo Akahane, Tetsuzo Tauchi, Seiichi Okabe, Kousuke Nunoda and Kazuma Ohyashiki

    Version of Record online : 21 APR 2008, DOI: 10.1111/j.1349-7006.2008.00810.x

  11. Adiponectin enhances Imatinib anti-tumour activity in human chronic myeloid leukaemia cells with serum levels associated with Imatinib efficacy in early chronic phase patients

    Cell Proliferation

    Volume 48, Issue 4, August 2015, Pages: 486–496, Guangshan Tan, Lei Shi, Qiang Li and Mingjun Wang

    Version of Record online : 6 JUL 2015, DOI: 10.1111/cpr.12194

  12. You have free access to this content
    Current and emerging treatment options in chronic myeloid leukemia

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2171–2181, Elias Jabbour, Jorge E. Cortes, Francis J. Giles, Susan O'Brien and Hagop M. Kantarjian

    Version of Record online : 12 APR 2007, DOI: 10.1002/cncr.22661

  13. You have free access to this content
    Transcription and signalling pathways involved in BCR–ABL-mediated misregulation of 24p3 and 24p3R

    The EMBO Journal

    Volume 28, Issue 7, April 8, 2009, Pages: 866–876, Zhi Sheng, Shu-Zong Wang and Michael R Green

    Version of Record online : 19 FEB 2009, DOI: 10.1038/emboj.2009.35

  14. You have free access to this content
    Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase

    Cancer

    Volume 116, Issue 6, 15 March 2010, Pages: 1419–1430, Hagop M. Kantarjian, Jorge Cortes, Paul La Rosée and Andreas Hochhaus

    Version of Record online : 29 JAN 2010, DOI: 10.1002/cncr.24928

  15. You have free access to this content
    Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 145, Issue 5, June 2009, Pages: 581–597, Franz Gruber, Satu Mustjoki and Kimmo Porkka

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1365-2141.2009.07666.x

  16. You have free access to this content
    Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease

    British Journal of Haematology

    Volume 142, Issue 3, August 2008, Pages: 361–378, Peter Valent

    Version of Record online : 6 JUN 2008, DOI: 10.1111/j.1365-2141.2008.07197.x

  17. You have free access to this content
    Site-specific cleavage of mutant ABL mRNA by DNAzyme is facilitated by peptide nucleic acid binding to RNA substrate

    FEBS Letters

    Volume 586, Issue 21, November 02, 2012, Pages: 3865–3869, Ji Eun Kim, Soojin Yoon, Hyejung Mok, Woong Jung and Dong-Eun Kim

    Version of Record online : 23 SEP 2012, DOI: 10.1016/j.febslet.2012.09.013

  18. You have full text access to this OnlineOpen article
    Combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells

    Cancer Science

    Volume 107, Issue 7, July 2016, Pages: 1029–1038, Yasufumi Matsuda, Takahiro Yamauchi, Naoko Hosono, Kanako Uzui, Eiju Negoro, Koji Morinaga, Rie Nishi, Akira Yoshida, Shinya Kimura, Taira Maekawa and Takanori Ueda

    Version of Record online : 21 JUN 2016, DOI: 10.1111/cas.12965

  19. Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia

    Journal of Cellular Physiology

    Volume 215, Issue 1, April 2008, Pages: 111–121, Riccardo Alessandro, Simona Fontana, Margherita Giordano, Chiara Corrado, Paolo Colomba, Anna Maria Flugy, Alessandra Santoro, Elise C. Kohn and Giacomo De Leo

    Version of Record online : 8 OCT 2007, DOI: 10.1002/jcp.21290

  20. You have full text access to this Open Access content
    Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitors

    Journal of Cellular and Molecular Medicine

    Volume 11, Issue 6, November/December 2007, Pages: 1251–1262, Shaoguang Li and Dongguang Li

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1582-4934.2007.00108.x